BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Memo Therapeutics increases Series C financing to CHF 45 million

  Memo Therapeutics AG announces that it has successfully raised CHF 20 million as part of an extension of its Series C financing, bringing the total amount raised in the funding round to CHF 45 million.

  May 7, 2024

   · 

  5 min read
• Business

  Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024

  Atea Pharmaceuticals, Inc. announced that it will host a live conference call and audio webcast on Tuesday, May 14, 2024, at 4:30 p.m. ET to report financial results for the first quarter ended March 31, 2024, and to provide a business update.

  May 7, 2024

   · 

  3 min read
• Business

  Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates

  Madrigal Pharmaceuticals, Inc. reports first-quarter 2024 financial results and provides corporate updates.

  May 7, 2024

   · 

  15 min read
• Business

  Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

  Neumora Therapeutics, Inc. announced financial results for the first quarter ended March 31, 2024, and provided a business update.

  May 7, 2024

   · 

  9 min read
• Bio NC

  BioCryst to Present at Upcoming May 2024 Investor Conferences

  BioCryst Pharmaceuticals, Inc. announced that the company will present at the following conferences.

  May 7, 2024

   · 

  1 min read
• Business

  Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results

  Theriva™ Biologics reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.

  May 7, 2024

   · 

  13 min read
• Business

  Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results

  Apellis Pharmaceuticals, Inc., announced its first quarter 2024 financial results and business highlights.

  May 7, 2024

   · 

  20 min read
• BioMidwest

  Bio-Techne to Present at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

  Bio-Techne Corporation announced it will showcase its portfolio of cell and gene therapy workflow solutions at the upcoming annual meeting of the American Society of Gene & Cell Therapy, taking place May 7-11, 2024, in Baltimore, Maryland.

  May 7, 2024

   · 

  4 min read
• BioMidwest

  Circular Genomics Announces New Research Demonstrating Accuracy of circRNA-based Test for Predicting Response to SSRI Antidepressant Treatment

  Circular Genomics announced study results published as a preprint on bioRXiv demonstrating the potential for Circular Genomics’ first blood assay to predict patient response to sertraline as well as capacity for SSRI class prediction overall.

  May 7, 2024

   · 

  4 min read
• Business

  Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates

  Fusion Pharmaceuticals Inc. reported financial results for the first quarter ended March 31, 2024, and provided an update on clinical and corporate developments.

  May 7, 2024

   · 

  15 min read